Search results
June's Biotech Boom: 3 Stocks to Buy for a Summertime Surge
InvestorPlace· 5 days agoBiotech surge alert! Discover three biotech stocks to buy as they catch up with the market in the...
Charles River Labs to open accelerator and development lab in Somerville - Boston Business Journal
The Business Journals· 4 days agoCharles River Laboratories International Inc. (NYSE: CRL) provides products and services to pharma ...
ASCO: Cautious Big Pharmas double down on past wins—steering clear of radioligands and cell therapy
FierceBiotech· 5 days ago“I think that people finally are showing up like in the old days,” Eliav Barr, M.D., Merck & Co.’s...
Phoreus Biotech’s new CEO shifts focus to human health market - Kansas City Business Journal
The Business Journals· 7 days agoAn Olathe-based biotech company’s new CEO is pivoting its focus from animal health to the more...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 2 hours agoMacomics continues to expand its leadership team to accelerate the development of first-in-class macrophage-targeted therapiesSimon Dew brings over 25 years of experience in pharmaceutical business development to advance partnerships for Macomics
The 3 Best Biotech Stocks to Buy in June 2024
InvestorPlace· 5 days agoThis was not surprising given the disparity between biotech’s high-capital requirements and rising interest rates set by the Fed. Despite these...
Three Indian CDMOs ready to seize the BIOSECURE Act opportunity
BioPharma-Reporter· 4 days agoSpearheading this effort is the BIOSECURE Act, a bipartisan initiative gaining traction in Congress...
Kairos Pharma, Ltd. Prices IPO at $4.00 Per Share (KAPA)
ETF DAILY NEWS· 4 days agoKairos Pharma, Ltd. (KAPA) expects to raise $6 million in an IPO on the week of June 10th, IPO Scoop...
MilliporeSigma Announces Siren Biotechnology As Winner Of Its North American Advance Biotech Grant
BioresearchOnline· 6 days agoMilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany,...
A weight loss drug maker's stock is rising on leaked clinical data
Quartz· 4 days agoZealand Pharma’s stock initially jumped 7% on Thursday, after results from a phase 2 clinical trial...
